Presentation is loading. Please wait.

Presentation is loading. Please wait.

U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The emergence of leukotriene modifiers and combination therapies.

Similar presentations


Presentation on theme: "U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The emergence of leukotriene modifiers and combination therapies."— Presentation transcript:

1 U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The emergence of leukotriene modifiers and combination therapies show promise in a highly competitive market. Convenience is the primary advantage of combination therapies, as these pills combine two or more asthma drugs into one dosage, making treatment more efficient.” Pharmaceuticals Analyst Team Frost & Sullivan

2 Detailed insights into recent developments and trends Drivers, restraints, challenges, and strategic recommendations Analytical insights into ‘hot topics’ and emerging applications in the asthma therapeutics market. Market-sizing and competitive analysis Market forecasts and opportunity analyses Quarterly assessments End-user analysis Key Features

3 Coverage: The United States Proven methodology using extensive primary and secondary data as well as research Focused information and strategies that cover business and technology issues Credible data and analyses that highlight industry dynamics Precise strategies to help you create winning business plans What We Offer

4 Current Market Participants Find out how you compare with the competition Assess current and future drivers as well as restraints Determine and exploit new market share opportunities New Entrants Analyze the associated challenges Calculate timescales for strategy implementation Position yourself to capitalize on the unmet needs of the market Investment Community Analyze long-term strategies of companies Determine which participants will outperform the competition Assess the attractiveness of investing in the market Who Will Benefit?

5 Alpharma, Inc./U.S. Pharmaceutical Division AstraZeneca AstraZeneca LP Aventis Pharmaceuticals, Inc. Bausch & Lomb Pharmaceuticals, Inc. Boehringer Ingelheim Gmbh Copley Pharmaceuticals, Inc. Dey, Inc. Dura Pharmaceuticals, Inc. Key Market Participants GlaxoSmithKline Medeva Pharmaceuticals, Inc. Novartis Pharmaceuticals Corp. Pfizer, Inc. Purdue Pharma LP Sanofi-Synthelabo, Inc. Schering-Plough Corp. Teva Pharmaceutials USA

6 Call toll free 877 G O F ROST (877.463.7876) Fax toll free 888.690.3329 E-mail myfrost@frost.com Visit www.frost.com For More Information


Download ppt "U.S. Asthma Therapeutics Market New Product Classes Offer Significant Growth Opportunities “The emergence of leukotriene modifiers and combination therapies."

Similar presentations


Ads by Google